» Articles » PMID: 33804762

Lung Ultrasound Patterns and Clinical-Laboratory Correlates During COVID-19 Pneumonia: A Retrospective Study from North East Italy

Abstract

Background And Aim: Lung ultrasound (LUS) is a convenient imaging modality in the setting of coronavirus disease-19 (COVID-19) because it is easily available, can be performed bedside and repeated over time. We herein examined LUS patterns in relation to disease severity and disease stage among patients with COVID-19 pneumonia.

Methods: We performed a retrospective case series analysis of patients with confirmed SARS-CoV-2 infection who were admitted to the hospital because of pneumonia. We recorded history, clinical parameters and medications. LUS was performed and scored in a standardized fashion by experienced operators, with evaluation of up to 12 lung fields, reporting especially on B-lines and consolidations.

Results: We included 96 patients, 58.3% men, with a mean age of 65.9 years. Patients with a high-risk quick COVID-19 severity index (qCSI) were older and had worse outcomes, especially for the need for high-flow oxygen. B-lines and consolidations were located mainly in the lower posterior lung fields. LUS patterns for B-lines and consolidations were significantly worse in all lung fields among patients with high versus low qCSI. B-lines and consolidations were worse in the intermediate disease stage, from day 7 to 13 after onset of symptoms. While consolidations correlated more with inflammatory biomarkers, B-lines correlated more with end-organ damage, including extrapulmonary involvement.

Conclusions: LUS patterns provide a comprehensive evaluation of patients with COVID-19 pneumonia that correlated with severity and dynamically reflect disease stage. LUS patterns may reflect different pathophysiological processes related to inflammation or tissue damage; consolidations may represent a more specific sign of localized disease, whereas B-lines seem to be also dependent upon generalized illness due to SARS-CoV-2 infection.

Citing Articles

Point-of-care lung ultrasound predicts hyperferritinemia and hospitalization, but not elevated troponin in SARS-CoV-2 viral pneumonitis in children.

Walsh P, Hankins A, Bang H Sci Rep. 2024; 14(1):5899.

PMID: 38467670 PMC: 10928070. DOI: 10.1038/s41598-024-55590-9.


The value of lung ultrasound score in neonatal respiratory distress syndrome: a prospective diagnostic cohort study.

Huang C, Zhang S, Ha X, Cui Y, Zhang H Front Med (Lausanne). 2024; 11:1357944.

PMID: 38390571 PMC: 10881781. DOI: 10.3389/fmed.2024.1357944.


Lung Ultrasound as a Triage Method in Primary Care for Patients with Suspected SARS-CoV-2 Pneumonia.

Guzman-Garcia M, Mohedano-Moriano A, Gonzalez-Gonzalez J, Morales-Cano J, Campo-Linares R, Lozano-Suarez C J Clin Med. 2022; 11(21).

PMID: 36362647 PMC: 9657854. DOI: 10.3390/jcm11216420.


Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit.

Gualtierotti R, Tafuri F, Rossio R, Rota M, Bucciarelli P, Ferrari B J Clin Med. 2022; 11(18).

PMID: 36143072 PMC: 9504266. DOI: 10.3390/jcm11185425.


New International Guidelines and Consensus on the Use of Lung Ultrasound.

Demi L, Wolfram F, Klersy C, De Silvestri A, Ferretti V, Muller M J Ultrasound Med. 2022; 42(2):309-344.

PMID: 35993596 PMC: 10086956. DOI: 10.1002/jum.16088.


References
1.
Colombi D, Petrini M, Maffi G, Villani G, Bodini F, Morelli N . Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence. Eur J Radiol. 2020; 133:109344. PMC: 7543736. DOI: 10.1016/j.ejrad.2020.109344. View

2.
Zieleskiewicz L, Markarian T, Lopez A, Taguet C, Mohammedi N, Boucekine M . Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia. Intensive Care Med. 2020; 46(9):1707-1713. PMC: 7388119. DOI: 10.1007/s00134-020-06186-0. View

3.
Deng Q, Zhang Y, Wang H, Chen L, Yang Z, Peng Z . Semiquantitative lung ultrasound scores in the evaluation and follow-up of critically ill patients with COVID-19: a single-center study. Acad Radiol. 2020; 27(10):1363-1372. PMC: 7359788. DOI: 10.1016/j.acra.2020.07.002. View

4.
Damiani S, Fiorentino M, De Palma A, Foschini M, Lazzarotto T, Gabrielli L . Pathological post-mortem findings in lungs infected with SARS-CoV-2. J Pathol. 2020; 253(1):31-40. DOI: 10.1002/path.5549. View

5.
Horby P, Mafham M, Linsell L, Bell J, Staplin N, Emberson J . Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 383(21):2030-2040. PMC: 7556338. DOI: 10.1056/NEJMoa2022926. View